| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr7:150997000-151002000 |
Weak transcription |
Gastric |
stomach
|
| 2 |
chr7:151000200-151002400 |
Enhancers |
Fetal Brain Male |
brain
|
| 3 |
chr7:151001000-151001800 |
Weak transcription |
H9 Cell Line |
embryonic stem cell
|
| 4 |
chr7:151001000-151001800 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
| 5 |
chr7:151001000-151001800 |
Weak transcription |
Ovary |
ovary
|
| 6 |
chr7:151001000-151001800 |
Weak transcription |
Right Atrium |
heart
|
| 7 |
chr7:151001000-151002000 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 8 |
chr7:151001000-151002000 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 9 |
chr7:151001000-151002000 |
Weak transcription |
Fetal Heart |
heart
|
| 10 |
chr7:151001000-151002200 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 11 |
chr7:151001000-151002200 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
| 12 |
chr7:151001000-151002200 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
| 13 |
chr7:151001000-151002200 |
Bivalent Enhancer |
Fetal Thymus |
thymus
|
| 14 |
chr7:151001000-151002400 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
| 15 |
chr7:151001000-151002400 |
Bivalent Enhancer |
Duodenum Mucosa |
Duodenum
|
| 16 |
chr7:151001000-151005400 |
Weak transcription |
Spleen |
Spleen
|
| 17 |
chr7:151001000-151008200 |
Weak transcription |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
| 18 |
chr7:151001200-151001800 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
| 19 |
chr7:151001200-151001800 |
Enhancers |
Primary T cells from cord blood |
blood
|
| 20 |
chr7:151001200-151001800 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
| 21 |
chr7:151001200-151001800 |
Weak transcription |
Fetal Lung |
lung
|
| 22 |
chr7:151001200-151002000 |
Active TSS |
HUES48 Cell Line |
embryonic stem cell
|
| 23 |
chr7:151001200-151002000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
| 24 |
chr7:151001200-151002000 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
| 25 |
chr7:151001200-151002200 |
Active TSS |
iPS-20b Cell Line |
embryonic stem cell
|
| 26 |
chr7:151001200-151002400 |
Active TSS |
iPS-15b Cell Line |
embryonic stem cell
|
| 27 |
chr7:151001200-151002400 |
Enhancers |
Placenta |
Placenta
|
| 28 |
chr7:151001200-151006000 |
Weak transcription |
Breast Myoepithelial Primary Cells |
Breast
|
| 29 |
chr7:151001400-151001800 |
Weak transcription |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
| 30 |
chr7:151001400-151002200 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
| 31 |
chr7:151001600-151001800 |
Bivalent Enhancer |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
| 32 |
chr7:151001600-151001800 |
Weak transcription |
Fetal Kidney |
kidney
|
| 33 |
chr7:151001600-151002200 |
Active TSS |
ES-WA7 Cell Line |
embryonic stem cell
|
| 34 |
chr7:151001600-151002200 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
| 35 |
chr7:151001600-151002200 |
Active TSS |
HUES6 Cell Line |
embryonic stem cell
|
| 36 |
chr7:151001600-151002200 |
Active TSS |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 37 |
chr7:151001600-151002200 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
